GB1473200A - Hypolipidemic alkenesulphonamides - Google Patents
Hypolipidemic alkenesulphonamidesInfo
- Publication number
- GB1473200A GB1473200A GB5275174A GB5275174A GB1473200A GB 1473200 A GB1473200 A GB 1473200A GB 5275174 A GB5275174 A GB 5275174A GB 5275174 A GB5275174 A GB 5275174A GB 1473200 A GB1473200 A GB 1473200A
- Authority
- GB
- United Kingdom
- Prior art keywords
- group
- carbon atoms
- alkyl group
- alkyl
- phenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
- C07D295/215—Radicals derived from nitrogen analogues of carbonic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/02—Preparation by ring-closure or hydrogenation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
- C07D211/16—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with acylated ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
- C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/38—Halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
- C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
- C07D217/06—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with the ring nitrogen atom acylated by carboxylic or carbonic acids, or with sulfur or nitrogen analogues thereof, e.g. carbamates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/08—Bridged systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
Abstract
1473200 Phenylalkenesulphonylureas PFIZER Inc 5 Dec 1974 [5 Dec 1973] 52751/74 Heading C2C The invention comprises novel compounds (I) and (II) and the salts thereof, wherein X is a hydrogen, fluorine, chlorine or bromine atom, a trifluoromethyl group, an alkyl group having one to four carbon atoms or an alkoxy group having from one to four carbon atoms, each of A and B, which may be the same or different, is a hydrogen atom or a methyl, ethyl or phenyl group, Z is a pyrrolidino, morpholino, thiomorpholino, 1,2,5,6-tetrahydropyridino, 1,2,3,4-tetrahydroisoquinolino, azacycloheptan - 1 - yl, azacyclooctan - 1 - yl, 3 - azabicyclo[3.2.2]nonan- 3 - yl, piperidino, 4 - hydroxypiperidino, 4- methoxypiperidino, 4-carboxypiperidino, 4-phenylpiperidino, alkylpiperidino having one to three carbon atoms in the alkyl group, (phenylalkyl) piperidino, having from one to five carbon atoms in the alkyl group, homopiperidino or ([substituted phenyl]alkyl)piperidino group having from one to five carbon atoms in the alkyl group, the said substituted phenyl group being substituted by a hydroxy group, an alkyl group having from one to four carbon atoms or an akoxy group having from one to four carbon atoms, and each of R<SP>1</SP> and R<SP>2</SP>, which may be the same or different, is a hydrogen atom or an alkyl group having from one to ten carbon atoms, an alkenyl group having from three to six carbon atoms, a cycloalkyl group having from three to seven carbon atoms, a phenylalkyl group having one or two carbon atoms in the alkyl group, a carboxyalkyl group having from one to seven carbon atoms in the alkyl group, an alkoxycarbonylalkyl group having one or two carbon atoms in the alkoxy group and having from one to seven carbon atoms in the alkyl group, or a bicyclo[2.2.1]hept-2-en-5-ylmethyl, 7-oxabicyclo[2.2.1]heptan-2-ylmethyl, bicyclo[2.2.1]heptan- 2 - ylmethyl, or phenyl group, or a phenyl group substituted by a fluorine, chlorine or bromine atom, or a nitro group, an alkyl group having from one to four carbon atoms or an alkoxy group having from one to four carbon atoms, provided that when both A and B are hydrogen atoms and either R<SP>1</SP> or R<SP>2</SP> is a hydrogen atom or an alkyl, alkenyl, cycloalkyl, phenyl or substituted phenyl group the other R<SP>1</SP> or R<SP>2</SP> is other than a hydrogen atom or an alkyl group. They are made by standard methods. Pharmaceutical preparations having hypolipidemic action contain (I) and/or (II) (the provisos not applying) as active ingredient. Administration is orally or parenterally.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US42208873A | 1973-12-05 | 1973-12-05 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1473200A true GB1473200A (en) | 1977-05-11 |
Family
ID=23673328
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB5275174A Expired GB1473200A (en) | 1973-12-05 | 1974-12-05 | Hypolipidemic alkenesulphonamides |
Country Status (18)
| Country | Link |
|---|---|
| JP (1) | JPS50111046A (en) |
| AR (2) | AR208187A1 (en) |
| AU (1) | AU7575774A (en) |
| BE (1) | BE822874A (en) |
| CA (1) | CA1042909A (en) |
| DD (1) | DD115491A5 (en) |
| DE (1) | DE2456947A1 (en) |
| DK (1) | DK144270C (en) |
| ES (1) | ES432573A1 (en) |
| FI (1) | FI351574A (en) |
| FR (1) | FR2253513B1 (en) |
| GB (1) | GB1473200A (en) |
| IE (1) | IE40430B1 (en) |
| IL (1) | IL46116A0 (en) |
| LU (1) | LU71425A1 (en) |
| NL (1) | NL7415796A (en) |
| NO (1) | NO744383L (en) |
| ZA (1) | ZA747728B (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019043610A1 (en) * | 2017-08-31 | 2019-03-07 | Cadila Healthcare Limited | Novel substituted sulfonylurea derivatives |
| WO2020148619A1 (en) * | 2019-01-14 | 2020-07-23 | Cadila Healthcare Limited | Novel substituted sulfonylurea derivatives |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3330603A1 (en) * | 1983-08-25 | 1985-03-21 | Hoechst Ag, 6230 Frankfurt | NEW 2-AMINO-ALKENYL-SULFONYL-UREAS |
| US5216026A (en) * | 1990-07-17 | 1993-06-01 | Eli Lilly And Company | Antitumor compositions and methods of treatment |
| JP2005500988A (en) * | 2001-03-23 | 2005-01-13 | ルイトポルド・ファーマシューティカルズ・インコーポレーテッド | Aliphatic amine drug complex |
| US7816398B2 (en) | 2001-03-23 | 2010-10-19 | Luitpold Pharmaceuticals, Inc. | Fatty alcohol drug conjugates |
-
1974
- 1974-01-01 AR AR256789A patent/AR208187A1/en active
- 1974-11-25 IL IL46116A patent/IL46116A0/en unknown
- 1974-11-26 AU AU75757/74A patent/AU7575774A/en not_active Expired
- 1974-12-02 DE DE19742456947 patent/DE2456947A1/en not_active Withdrawn
- 1974-12-03 BE BE151087A patent/BE822874A/en unknown
- 1974-12-04 NO NO744383A patent/NO744383L/no unknown
- 1974-12-04 LU LU71425A patent/LU71425A1/xx unknown
- 1974-12-04 ZA ZA00747728A patent/ZA747728B/en unknown
- 1974-12-04 DK DK629974A patent/DK144270C/en not_active IP Right Cessation
- 1974-12-04 DD DD182788A patent/DD115491A5/xx unknown
- 1974-12-04 NL NL7415796A patent/NL7415796A/en not_active Application Discontinuation
- 1974-12-04 ES ES432573A patent/ES432573A1/en not_active Expired
- 1974-12-04 FI FI3515/74A patent/FI351574A/fi unknown
- 1974-12-04 CA CA215,239A patent/CA1042909A/en not_active Expired
- 1974-12-05 IE IE2515/74A patent/IE40430B1/en unknown
- 1974-12-05 FR FR7439786A patent/FR2253513B1/fr not_active Expired
- 1974-12-05 JP JP49140047A patent/JPS50111046A/ja active Pending
- 1974-12-05 GB GB5275174A patent/GB1473200A/en not_active Expired
-
1975
- 1975-10-23 AR AR260897A patent/AR211918A1/en active
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019043610A1 (en) * | 2017-08-31 | 2019-03-07 | Cadila Healthcare Limited | Novel substituted sulfonylurea derivatives |
| WO2020148619A1 (en) * | 2019-01-14 | 2020-07-23 | Cadila Healthcare Limited | Novel substituted sulfonylurea derivatives |
Also Published As
| Publication number | Publication date |
|---|---|
| IE40430B1 (en) | 1979-05-23 |
| DD115491A5 (en) | 1975-10-05 |
| AR211918A1 (en) | 1978-04-14 |
| FR2253513A1 (en) | 1975-07-04 |
| ES432573A1 (en) | 1976-11-01 |
| JPS50111046A (en) | 1975-09-01 |
| IE40430L (en) | 1975-06-05 |
| DK144270B (en) | 1982-02-01 |
| AR208187A1 (en) | 1976-12-09 |
| CA1042909A (en) | 1978-11-21 |
| IL46116A0 (en) | 1975-02-10 |
| AU7575774A (en) | 1976-05-27 |
| NO744383L (en) | 1975-06-30 |
| DE2456947A1 (en) | 1975-06-12 |
| DK144270C (en) | 1982-07-12 |
| FR2253513B1 (en) | 1978-07-28 |
| NL7415796A (en) | 1975-06-09 |
| DK629974A (en) | 1975-07-21 |
| ZA747728B (en) | 1976-02-25 |
| FI351574A (en) | 1975-06-06 |
| LU71425A1 (en) | 1975-08-20 |
| BE822874A (en) | 1975-06-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ218786A (en) | 1,4 disubstituted piperidine derivatives and pharmaceutical compositions | |
| IE821768L (en) | Pyrrolidine derivatives | |
| NO942952D0 (en) | 11-benzaldoxyn-17 aters, a process for their preparation and a medicament containing such | |
| GB1473200A (en) | Hypolipidemic alkenesulphonamides | |
| GB1342520A (en) | Alpha-alkyl-substituted benzyl or thenyl-benzyloxy derivatives of amines | |
| IE32453L (en) | Pteridine derivatives | |
| GB1260768A (en) | N-alkyl-tetrahydrocarbazoles | |
| GB1274652A (en) | Adamantanyl-alkylamine derivatives and their preparation | |
| KR930010016A (en) | Saccharin Derivatives, Protease Inhibitors | |
| GB1309679A (en) | Substituted sulphonanilides | |
| ES453162A1 (en) | 6-Oxa-1-aza tricyclo dodecan-5-ones as psychomotor stimulators | |
| GB1304069A (en) | ||
| ES8200355A1 (en) | Morpholine derivatives, process for their production, pharmaceutical preparations containing these derivatives. | |
| IE41219B1 (en) | Aralkyl esters of aminoalkanoic acids | |
| GB1373368A (en) | Hydroxyalkyl substituted 4,5-dihydro-pyridazin-2h-3-ones | |
| GB1405767A (en) | Method formulation and pharmaceutical composition for reducing plasma lipid levels | |
| GB1415682A (en) | Amides and thioamides | |
| GB1269774A (en) | Benzodioxole compounds | |
| ES8101583A1 (en) | Cardiovascular regulating agent quinazoline | |
| IE42710L (en) | Piperazine derivative | |
| ES8301994A1 (en) | Tetrahydrothiopyrano(3,2-b)indole derivatives, process for their preparation and pharmaceutical composition containing these compounds. | |
| ES385522A1 (en) | Azamorphinan compounds | |
| ES345691A1 (en) | 2-aminomethyl benzofuran derivatives | |
| GB1472325A (en) | Substituted-3,3a,4,5,6,7-hexahydropyrazolo-4,3-c-pyridines | |
| GB1317125A (en) | Piperazine compositions and method of treatment |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PS | Patent sealed [section 19, patents act 1949] | ||
| PCNP | Patent ceased through non-payment of renewal fee |